New Jersey Statutes 24:6B-1. Registration statement, issuance of registration
Current as of: 2023 | Check for updates
|
Other versions
Terms Used In New Jersey Statutes 24:6B-1
- Drug: means (1) articles recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them. See New Jersey Statutes 24:1-1
- person: includes corporations, companies, associations, societies, firms, partnerships and joint stock companies as well as individuals, unless restricted by the context to an individual as distinguished from a corporate entity or specifically restricted to one or some of the above enumerated synonyms and, when used to designate the owner of property which may be the subject of an offense, includes this State, the United States, any other State of the United States as defined infra and any foreign country or government lawfully owning or possessing property within this State. See New Jersey Statutes 1:1-2
- State: extends to and includes any State, territory or possession of the United States, the District of Columbia and the Canal Zone. See New Jersey Statutes 1:1-2
1. No person shall hereafter engage or continue to engage in a drug manufacturing business or a wholesale non-prescription drug business in this State without first filing a completed registration statement with the department. The department shall promptly review completed registration statements. Within 30 days after receipt of a registration statement, the department shall either issue registration, or shall advise the registrant, in writing, of the specific deficiencies in the registration statement. Any supplemental materials, which are submitted in response to a notice of deficiency, shall be reviewed by the department within 30 days after receipt thereof.
L.1961, c.52, s.1; amended 2005, c.206, s.1; 2016, c.73, s.1.